Available datapackage for study 'A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study).'

Vivli 2026 Dataset Open access

Read full text
Authors: AstraZeneca
DOI: 10.25934/pr00011845.0
Cited by: 0

Abstract

The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus.

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Diabetes Treatment and Management Acute Myocardial Infarction Research

Publication details

Journal / source
Vivli
Publication date
18 January 2026
Language
EN
Document type
Dataset